相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Vasodilatory Activity of CGRP: A Response
Marcelo E. Bigal et al.
HEADACHE (2014)
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
Sarah Walter et al.
MABS (2014)
Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention
Tony W. Ho et al.
NEUROLOGY (2014)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
Marcelo E. Bigal et al.
HEADACHE (2013)
Is CGRP a marker for chronic migraine?
Stephen D. Silberstein et al.
NEUROLOGY (2013)
A Randomized, Placebo-Controlled Study of the Effects of Telcagepant on Exercise Time in Patients With Stable Angina
B. R. Chaitman et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors
Jan Hoffmann et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2012)
The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men
Bart J. Van der Schueren et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine
David J. Hewitt et al.
CEPHALALGIA (2011)
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
Ann C. Raddant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Characterization of the Calcitonin Gene-Related Peptide Receptor Antagonist Telcagepant (MK-0974) in Human Isolated Coronary Arteries
K. Y. Chan et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
CGRP and its receptors provide new insights into migraine pathophysiology
Tony W. Ho et al.
NATURE REVIEWS NEUROLOGY (2010)
Possible sites of action of the new calcitonin gene-related peptide receptor antagonists
Sajedeh Eftekhari et al.
Therapeutic Advances in Neurological Disorders (2010)
Effects of the prototype serotonin 5-HT1B/1D receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP8-37 on myocardial reactive hyperemic response in conscious dogs
Joseph J. Lynch et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2009)
Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactlivity in the rat trigeminovascular system:: Differences between peripheral and central CGRP receptor distribution
Jochen K. Lennerz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2008)
Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial
Tony W. Ho et al.
LANCET (2008)
Calcitonin gene-related peptide (CGRP) antagonists and migraine - Is this a new era?
Peter J. Goadsby
NEUROLOGY (2008)
Neuron-glia signaling in trigeminal ganglion: Implications for migraine pathology
Srikanth Thalakoti et al.
HEADACHE (2007)
Analysis of the cellular expression pattern of β-CGRP in α-CGRP-deficient mice
B Schütz et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
分享论文
